EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome: update 2023: review
On behalf of the EORTC Cutaneous Lymphoma Tumours Group (EORTC-CLTG) and following up on earlier versions published in 2006 and 2017 this document provides an updated standard for the treatment of mycosis fungoides and Sézary syndrome (MF/SS). It considers recent relevant publications and treatment...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
December 2023
|
| In: |
European journal of cancer
Year: 2023, Jahrgang: 195, Pages: 1-16 |
| ISSN: | 1879-0852 |
| DOI: | 10.1016/j.ejca.2023.113343 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1016/j.ejca.2023.113343 Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S0959804923006457 
|
| Verfasserangaben: | Johanna Latzka, Chalid Assaf, Martine Bagot, Antonio Cozzio, Reinhard Dummer, Emmanuella Guenova, Robert Gniadecki, Emmilia Hodak, Constanze Jonak, Claus-Detlev Klemke, Robert Knobler, Stephen Morrris, Jan P. Nicolay, Pablo L. Ortiz-Romero, Evangelia Papadavid, Nicola Pimpinelli, Pietro Quaglino, Annamari Ranki, Julia Scarisbrick, Rudolf Stadler, Liisa Väkevä, Maarten H. Vermeer, Ulrike Wehkamp, Sean Whittaker, Rein Willemze, Franz Trautinger |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1885911475 | ||
| 003 | DE-627 | ||
| 005 | 20240703164738.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240416s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ejca.2023.113343 |2 doi | |
| 035 | |a (DE-627)1885911475 | ||
| 035 | |a (DE-599)KXP1885911475 | ||
| 035 | |a (OCoLC)1443668466 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Latzka, Johanna |e VerfasserIn |0 (DE-588)1326291025 |0 (DE-627)1885911858 |4 aut | |
| 245 | 1 | 0 | |a EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome |b update 2023: review |c Johanna Latzka, Chalid Assaf, Martine Bagot, Antonio Cozzio, Reinhard Dummer, Emmanuella Guenova, Robert Gniadecki, Emmilia Hodak, Constanze Jonak, Claus-Detlev Klemke, Robert Knobler, Stephen Morrris, Jan P. Nicolay, Pablo L. Ortiz-Romero, Evangelia Papadavid, Nicola Pimpinelli, Pietro Quaglino, Annamari Ranki, Julia Scarisbrick, Rudolf Stadler, Liisa Väkevä, Maarten H. Vermeer, Ulrike Wehkamp, Sean Whittaker, Rein Willemze, Franz Trautinger |
| 264 | 1 | |c December 2023 | |
| 300 | |b Illustrationen | ||
| 300 | |a 16 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Available online 18 September 2023, Version of Record 25 October 2023 | ||
| 500 | |a Gesehen am 16.04.2024 | ||
| 520 | |a On behalf of the EORTC Cutaneous Lymphoma Tumours Group (EORTC-CLTG) and following up on earlier versions published in 2006 and 2017 this document provides an updated standard for the treatment of mycosis fungoides and Sézary syndrome (MF/SS). It considers recent relevant publications and treatment options introduced into clinical practice after 2017. Consensus was established among the authors through a series of consecutive consultations in writing and a round of discussion. Treatment options are assigned to each disease stage and, whenever possible and clinically useful, separated into first- and second line options annotated with levels of evidence. Major changes to the previous version include the incorporation of chlormethine, brentuximab vedotin, and mogamulizumab, recommendations on the use of pegylated interferon α (after withdrawal of recombinant unpegylated interferons), and the addition of paragraphs on supportive therapy and on the care of older patients. Still, skin-directed therapies are the most appropriate option for early-stage MF and most patients have a normal life expectancy but may suffer morbidity and impaired quality of life. In advanced disease treatment options have expanded recently. Most patients receive multiple consecutive therapies with treatments often having a relatively short duration of response. For those patients prognosis is still poor and only for a highly selected subset long term remission can be achieved with allogeneic stem cell transplantation. Understanding of the disease, its epidemiology and clinical course, and its most appropriate management are gradually advancing, and there is well-founded hope that this will lead to further improvements in the care of patients with MF/SS. | ||
| 650 | 4 | |a Chemotherapy | |
| 650 | 4 | |a Corticosteroids | |
| 650 | 4 | |a Cutaneous T-cell lymphomas | |
| 650 | 4 | |a Immunotherapy | |
| 650 | 4 | |a Mycosis fungoides | |
| 650 | 4 | |a Phototherapy | |
| 650 | 4 | |a Radiotherapy | |
| 650 | 4 | |a Retinoids | |
| 650 | 4 | |a Sézary syndrome | |
| 650 | 4 | |a Total skin electron beam therapy | |
| 700 | 1 | |a Assaf, Chalid |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bagot, Martine |e VerfasserIn |4 aut | |
| 700 | 1 | |a Cozzio, Antonio |e VerfasserIn |4 aut | |
| 700 | 1 | |a Dummer, Reinhard |e VerfasserIn |4 aut | |
| 700 | 1 | |a Guenova, Emmanuella |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gniadecki, Robert |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hodak, Emmilia |e VerfasserIn |4 aut | |
| 700 | 1 | |a Jonak, Constanze |e VerfasserIn |4 aut | |
| 700 | 1 | |a Klemke, Claus-Detlev |e VerfasserIn |4 aut | |
| 700 | 1 | |a Knobler, Robert |e VerfasserIn |4 aut | |
| 700 | 1 | |a Morrris, Stephen |e VerfasserIn |4 aut | |
| 700 | 1 | |a Nicolay, Jan Peter |d 1981- |e VerfasserIn |0 (DE-588)138614474 |0 (DE-627)604867352 |0 (DE-576)308046188 |4 aut | |
| 700 | 1 | |a Ortiz-Romero, Pablo L. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Papadavid, Evangelia |e VerfasserIn |4 aut | |
| 700 | 1 | |a Pimpinelli, Nicola |e VerfasserIn |4 aut | |
| 700 | 1 | |a Quaglino, Pietro |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ranki, Annamari |e VerfasserIn |4 aut | |
| 700 | 1 | |a Scarisbrick, Julia |e VerfasserIn |4 aut | |
| 700 | 1 | |a Stadler, Rudolf |e VerfasserIn |4 aut | |
| 700 | 1 | |a Väkevä, Liisa |e VerfasserIn |4 aut | |
| 700 | 1 | |a Vermeer, Maarten H. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Wehkamp, Ulrike |e VerfasserIn |4 aut | |
| 700 | 1 | |a Whittaker, Sean |e VerfasserIn |4 aut | |
| 700 | 1 | |a Willemze, Rein |e VerfasserIn |4 aut | |
| 700 | 1 | |a Trautinger, Franz |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of cancer |d Amsterdam [u.a.] : Elsevier, 1992 |g 195(2023), Seite 1-16 |w (DE-627)266883400 |w (DE-600)1468190-0 |w (DE-576)090954173 |x 1879-0852 |7 nnas |a EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome update 2023: review |
| 773 | 1 | 8 | |g volume:195 |g year:2023 |g pages:1-16 |g extent:16 |a EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome update 2023: review |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.ejca.2023.113343 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S0959804923006457 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20240416 | ||
| 993 | |a Article | ||
| 994 | |a 2023 | ||
| 998 | |g 138614474 |a Nicolay, Jan Peter |m 138614474:Nicolay, Jan Peter |d 60000 |d 61900 |e 60000PN138614474 |e 61900PN138614474 |k 0/60000/ |k 1/60000/61900/ |p 13 | ||
| 999 | |a KXP-PPN1885911475 |e 4512429123 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"recId":"1885911475","language":["eng"],"name":{"displayForm":["Johanna Latzka, Chalid Assaf, Martine Bagot, Antonio Cozzio, Reinhard Dummer, Emmanuella Guenova, Robert Gniadecki, Emmilia Hodak, Constanze Jonak, Claus-Detlev Klemke, Robert Knobler, Stephen Morrris, Jan P. Nicolay, Pablo L. Ortiz-Romero, Evangelia Papadavid, Nicola Pimpinelli, Pietro Quaglino, Annamari Ranki, Julia Scarisbrick, Rudolf Stadler, Liisa Väkevä, Maarten H. Vermeer, Ulrike Wehkamp, Sean Whittaker, Rein Willemze, Franz Trautinger"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"id":{"doi":["10.1016/j.ejca.2023.113343"],"eki":["1885911475"]},"origin":[{"dateIssuedDisp":"December 2023","dateIssuedKey":"2023"}],"note":["Available online 18 September 2023, Version of Record 25 October 2023","Gesehen am 16.04.2024"],"physDesc":[{"extent":"16 S.","noteIll":"Illustrationen"}],"relHost":[{"recId":"266883400","id":{"zdb":["1468190-0"],"eki":["266883400"],"issn":["1879-0852"]},"pubHistory":["28.1992 -"],"note":["Gesehen am 21.03.24","Ungezählte Beil.: Supplement"],"origin":[{"publisherPlace":"Amsterdam [u.a.] ; [Erscheinungsort nicht ermittelbar]","dateIssuedKey":"1992","dateIssuedDisp":"1992-","publisher":"Elsevier ; Pergamon Press"}],"language":["eng"],"disp":"EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome update 2023: reviewEuropean journal of cancer","titleAlt":[{"title":"EJC online"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"title":[{"title":"European journal of cancer","title_sort":"European journal of cancer"}],"corporate":[{"display":"European Organization for Research on Treatment of Cancer","role":"isb"},{"display":"European Association for Cancer Research","role":"isb"},{"display":"European School of Oncology","role":"isb"}],"part":{"pages":"1-16","text":"195(2023), Seite 1-16","volume":"195","year":"2023","extent":"16"}}],"person":[{"family":"Latzka","given":"Johanna","display":"Latzka, Johanna","role":"aut"},{"given":"Chalid","family":"Assaf","role":"aut","display":"Assaf, Chalid"},{"given":"Martine","family":"Bagot","role":"aut","display":"Bagot, Martine"},{"family":"Cozzio","given":"Antonio","display":"Cozzio, Antonio","role":"aut"},{"family":"Dummer","given":"Reinhard","role":"aut","display":"Dummer, Reinhard"},{"display":"Guenova, Emmanuella","role":"aut","family":"Guenova","given":"Emmanuella"},{"family":"Gniadecki","given":"Robert","display":"Gniadecki, Robert","role":"aut"},{"family":"Hodak","given":"Emmilia","role":"aut","display":"Hodak, Emmilia"},{"display":"Jonak, Constanze","role":"aut","given":"Constanze","family":"Jonak"},{"given":"Claus-Detlev","family":"Klemke","display":"Klemke, Claus-Detlev","role":"aut"},{"display":"Knobler, Robert","role":"aut","family":"Knobler","given":"Robert"},{"role":"aut","display":"Morrris, Stephen","given":"Stephen","family":"Morrris"},{"given":"Jan Peter","family":"Nicolay","display":"Nicolay, Jan Peter","role":"aut"},{"display":"Ortiz-Romero, Pablo L.","role":"aut","family":"Ortiz-Romero","given":"Pablo L."},{"role":"aut","display":"Papadavid, Evangelia","family":"Papadavid","given":"Evangelia"},{"family":"Pimpinelli","given":"Nicola","display":"Pimpinelli, Nicola","role":"aut"},{"family":"Quaglino","given":"Pietro","role":"aut","display":"Quaglino, Pietro"},{"role":"aut","display":"Ranki, Annamari","given":"Annamari","family":"Ranki"},{"family":"Scarisbrick","given":"Julia","display":"Scarisbrick, Julia","role":"aut"},{"display":"Stadler, Rudolf","role":"aut","given":"Rudolf","family":"Stadler"},{"given":"Liisa","family":"Väkevä","role":"aut","display":"Väkevä, Liisa"},{"given":"Maarten H.","family":"Vermeer","role":"aut","display":"Vermeer, Maarten H."},{"family":"Wehkamp","given":"Ulrike","display":"Wehkamp, Ulrike","role":"aut"},{"given":"Sean","family":"Whittaker","role":"aut","display":"Whittaker, Sean"},{"family":"Willemze","given":"Rein","display":"Willemze, Rein","role":"aut"},{"given":"Franz","family":"Trautinger","display":"Trautinger, Franz","role":"aut"}],"title":[{"subtitle":"update 2023: review","title":"EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome","title_sort":"EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome"}]} | ||
| SRT | |a LATZKAJOHAEORTCCONSE2023 | ||